Pradaxa 411 | Lawsuit Side Effects of Pradaxa, Dabigatran Blood Thinner Lawsuit
Don’t neglect dabigatran side effects. If you are suffering from complications after consuming the drug, file pradaxa blood thinner lawsuit with our lawyers.
pradaxa lawsuit side effects of pradaxa
15254
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-15254,ajax_fade,page_not_loaded,,qode-title-hidden,footer_responsive_adv,qode-theme-ver-10.0,wpb-js-composer js-comp-ver-4.12,vc_responsive

YOU DESERVE
COMPENSATION

Injured by the dangerous drug Pradaxa?

You have come to the right place. We help thousands of people just like you get the legal help they need. Victims of dangerous drugs or medical devices can suffer serious injury or death; therefore, it’s critical to have the strongest legal representation available.

FREE EVALUATION

There is no fee unless you are awarded compensation.

YOU DESERVE COMPENSATION

Injured by a dangerous drug or medical device?

You have come to the right place. We help thousands of people just like you get the legal help they need. Victims of dangerous drugs or medical devices can suffer serious injury or death; therefore, it’s critical to have the strongest legal representation available. In your time of need, look to us as your trusted source. We are standing by to help.

FREE EVALUATION

No legal fee unless awarded compensation.

State and Federal

4,000

Total amount of lawsuits that claimed the drug caused symptoms that resulted in hundreds of deaths.

May 2014

$650 Million

Boehringer Ingelheim Pharmaceuticals announced it would settle the lawsuits in order to avoid lengthy litigation.

Early 2011

$464 Million

Boehringer spent this much money promoting Pradaxa through direct-to-consumer advertising and other means of marketing.

State and Federal

4,000

Total lawsuits that claimed the drug caused sudden uncontrollable gastrointestinal, rectal and brain bleeding that resulted in hundreds of deaths.

May 2014

$650 Million

Pradaxa manufacturer, Boehringer Ingelheim Pharmaceuticals, announced it would settle the lawsuits in order to avoid lengthy litigation.

Boehringer spent:

$464 Million

Promoting Pradaxa through direct-to-consumer advertising and other means of marketing.

PRADAXA OVERVIEW

Pradaxa (dabigatran) helps to prevent platelets in your blood from sticking together and forming a blood clot. Pradaxa is used to reduce the risk of stroke and blood clots in people who have a medical condition called atrial fibrillation. Pradaxa is also used to treat blood clots in the veins of your legs (deep vein thrombosis, or DVT) or lungs (pulmonary embolism, or PE) and reduce the risk of them occurring again.

RECENT SETTLEMENT

$650
Million

In May of 2014, lawyers for Boehringer Ingelheim and those victims suffering internal bleeding reached a settlement of $650 million for what was supposed to be around 3,600 people. However, by the end of the settlement, more than 4,000 victims were included. The first Pradaxa settlement was reached before a single case made it to a jury trial. This provided guaranteed compensation for thousands of victims.

SIDE EFFECTS

Pradaxa can cause a very serious blood clot around your spinal cord if you undergo a spinal tap or receive spinal anesthesia (epidural), especially if you have a genetic spinal defect, if you have a spinal catheter in place, if you have a history of spinal surgery or repeated spinal taps, or if you are also using other drugs that can affect blood clotting. This type of blood clot can lead to long-term or permanent paralysis. Bleeding is the most serious side effect reported with dabigatran (the active ingredient contained in Pradaxa). Major or severe bleeding may occur and, regardless of location, may lead to disabling, life-threatening or even fatal outcomes.

No legal fees unless you are awarded compensation

No legal fees unless you are awarded compensation

Common Side Effects Include

  • Death
  • Internal Bleeding
  • Hospitalization
  • Gastrointestinal Bleeding
  • Kidney Bleeding
  • Pain
  • Brain Hemorrhaging
  • Suffering

Common Side Effects Include

  • Death
  • Internal Bleeding
  • Hospitalization
  • Gastrointestinal Bleeding
  • Kidney Bleeding
  • Pain
  • Brain Hemorrhaging
  • Suffering

Receive a free evaluation and find out if you qualify.

FIND OUT IF YOU QUALIFY AND RECEIVE A FREE EVALUATION.

Let Us Fight For Your Rights

Pradaxa was approved by the FDA in October 2010. The principal side effects listed at the time of approval were dyspepsia (indigestion) and gastritis (inflammation of the lining of the stomach).

 

In April 2013, the FDA required Pradaxa’s label to include a “black box warning,” the strongest caution available to the agency. The new label included the following language: “WARNING: DISCONTINUING PRADAXA IN PATIENTS WITHOUT ADEQUATE CONTINUOUS ANTICOAGULATION INCREASES RISK OF STROKE.” The label also added another adverse reaction reported by Pradaxa users to the FDA: thrombocytopenia (abnormally low number of platelets in the blood). December 2013 saw yet another new complication reported by Pradaxa users that the FDA required to be added to the drug’s label. Esophageal ulcers had been reported to the agency as an adverse event, and the FDA required its inclusion on the label as a possible complication of Pradaxa use.

 

The FDA’s many required revisions to the Pradaxa label implies that the drug’s original labeling failed to provide adequate warning to patients and physicians about Pradaxa’s many serious and life-threatening complications. To date, the agency has yet to issue a Pradaxa recall, despite escalating concerns about internal bleeding risks.

Let Us Fight For Your Rights

Pradaxa was approved by the FDA in October 2010. The principal side effects listed at the time of approval were dyspepsia (indigestion) and gastritis (inflammation of the lining of the stomach).

 

In April 2013, the FDA required Pradaxa’s label to include a “black box warning,” the strongest caution available to the agency. The new label included the following language: “WARNING: DISCONTINUING PRADAXA IN PATIENTS WITHOUT ADEQUATE CONTINUOUS ANTICOAGULATION INCREASES RISK OF STROKE.” The label also added another adverse reaction reported by Pradaxa users to the FDA: thrombocytopenia (abnormally low number of platelets in the blood). December 2013 saw yet another new complication reported by Pradaxa users that the FDA required to be added to the drug’s label. Esophageal ulcers had been reported to the agency as an adverse event, and the FDA required its inclusion on the label as a possible complication of Pradaxa use.

 

The FDA’s many required revisions to the Pradaxa label implies that the drug’s original labeling failed to provide adequate warning to patients and physicians about Pradaxa’s many serious and life-threatening complications. To date, the agency has yet to issue a Pradaxa recall, despite escalating concerns about internal bleeding risks.

FAQ’s

What legal options are available to Pradaxa patients and their loved ones?

Patients who suffered serious bleeding events while taking Pradaxa, as well as loved ones acting on their behalf may be able to file a claim against the manufacturer for compensation. To learn more about your eligibility for legal recourse, contact us today for a free case review.

 

Does Pradaxa increase the risk of gastrointestinal bleeding?

Several studies have shown that Pradaxa puts patients at an increased risk for gastrointestinal (GI) bleeding than the traditional anticoagulants, including the initial trial that helped get Pradaxa approved by the FDA. One study published found users of Pradaxa were more than 1.5-times more likely to suffer from gastrointestinal bleeding than users or warfarin. The study also found patients taking Pradaxa were 1.3-times more likely to suffer from any sort of bleeding episode compared to patients taking warfarin.

 

Are there lawsuits against the makers of Pradaxa?

There is pending litigation against the makers of Pradaxa in U.S. federal court. The lawsuits allege the company failed to adequately warn consumers about the potential risks of the drug. Thousands of lawsuits were consolidated in a multi-district litigation (MDL) in the U.S. District Court for the Southern District of Illinois. Currently, four are pending in the MDL overseen by U.S. District Judge David R. Herndon. In 2014, Boehringer-Ingelheim announced it would settle roughly 4,000 cases pending in federal court for $650 million. The company did not admit wrongdoing even though it agreed to a settlement.

FAQ’s

What legal options are available to Pradaxa patients and their loved ones?

Patients who suffered serious bleeding events while taking Pradaxa, as well as loved ones acting on their behalf may be able to file a claim against the manufacturer for compensation. To learn more about your eligibility for legal recourse, contact us today for a free case review.

 

Does Pradaxa increase the risk of gastrointestinal bleeding?

Several studies have shown that Pradaxa puts patients at an increased risk for gastrointestinal (GI) bleeding than the traditional anticoagulants, including the initial trial that helped get Pradaxa approved by the FDA. One study published found users of Pradaxa were more than 1.5-times more likely to suffer from gastrointestinal bleeding than users or warfarin. The study also found patients taking Pradaxa were 1.3-times more likely to suffer from any sort of bleeding episode compared to patients taking warfarin.

 

Are there lawsuits against the makers of Pradaxa?

There is pending litigation against the makers of Pradaxa in U.S. federal court. The lawsuits allege the company failed to adequately warn consumers about the potential risks of the drug. Thousands of lawsuits were consolidated in a multi-district litigation (MDL) in the U.S. District Court for the Southern District of Illinois. Currently, four are pending in the MDL overseen by U.S. District Judge David R. Herndon. In 2014, Boehringer-Ingelheim announced it would settle roughly 4,000 cases pending in federal court for $650 million. The company did not admit wrongdoing even though it agreed to a settlement.

This could be the most important call of your life.
855-228-3953

This could be the most important call of your life.
855-228-3953

This could be the most important call of your life.

855-228-3953

FREE EVALUATION

There is no fee unless you are awarded compensation.

YOU MAY BE ENTITLED TO
FINANCIAL COMPENSATION

There is no fee unless you are awarded compensation, but don’t wait time may be running out to file your claim.

If you have suffered an injury caused by a dangerous drug or medical device, start the process for a free evaluation, simply call us now or fill out the form on this page.

YOU MAY BE ENTITLED TO
FINANCIAL COMPENSATION

There is no fee unless you are awarded compensation, but don’t wait time may be running out to file your claim.

If you have suffered an injury caused by the dangerous drug Pradaxa, start the process for a free evaluation right now by filling out the form on this page.

FREE EVALUATION

No legal fee unless awarded compensation.